A. O. Anoprienko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. O. Anoprienko has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- A. V. Tyurina
Rostov-on-Don Research Anti-Plague Institute
3 shared publications - M. P. Pogozhova
Rostov-on-Don Research Anti-Plague Institute
3 shared publications - Natalia E. Gayevskaya
Rostov-on-Don Research Anti-Plague Institute
3 shared publications - Anastasia A. Trufanova
Rostov-on-Don Anti-Plague Institute of Rospotrebnadzor
2 shared publications - Anna V. Filippenko
Rostov-on-Don Anti-Plague Institute of Rospotrebnadzor
2 shared publications - Inna A. Ivanova
Rostov-on-Don Anti-Plague Institute of Rospotrebnadzor
2 shared publications
Latest Publications
- Open Access
- 3 July 2024
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 2,p. 193-195
Assessment of the Effectiveness of Cholera Bacteriophages for Prevention of Experimental Cholera
The possibility of cholera importation into our country and the increase in the number of Vibrio cholerae strains that are resistant to antibacterial agents necessitate the development of alternative therapeutic and prophylactic biological products based on bacteriophages.The aim of the work was to study the effectiveness of application of cholera bacteriophages for the prevention of experimental cholera.Materials and methods. The work involved cholera bacteriophages Rostov-M3, Rostov-13, active against cholera vibrios of the O1 serogroup; and FB1, which has lytic activity against the O139 serogroup. The effectiveness of cholera prevention was assessed using a model of an isolated loop of the small intestine in an adult rabbit.Results and discussion. The use of Rostov-M3 and Rostov-13 for five and especially seven days before infection with virulent strains of V. cholerae O1 serogroup prevents the development of infection in the small intestine of experimental animals. Bacteriophage FB1 did not have that ability against V. cholerae O139. These studies indicate the effectiveness of using phages Rostov-M3 and Rostov-13 for the prevention of experimental cholera caused by V. cholerae O1 serogroup.
- 3 July 2024
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 2,p. 193-195
Open AccessAssessment of the Effectiveness of Cholera Bacteriophages for Prevention of Experimental Cholera
The possibility of cholera importation into our country and the increase in the number of Vibrio cholerae strains that are resistant to antibacterial agents necessitate the development of alternative therapeutic and prophylactic biological products based on bacteriophages.The aim of the work was to study the effectiveness of application of cholera bacteriophages for the prevention of experimental cholera.Materials and methods. The work involved cholera bacteriophages Rostov-M3, Rostov-13, active against cholera vibrios of the O1 serogroup; and FB1, which has lytic activity against the O139 serogroup. The effectiveness of cholera prevention was assessed using a model of an isolated loop of the small intestine in an adult rabbit.Results and discussion. The use of Rostov-M3 and Rostov-13 for five and especially seven days before infection with virulent strains of V. cholerae O1 serogroup prevents the development of infection in the small intestine of experimental animals. Bacteriophage FB1 did not have that ability against V. cholerae O139. These studies indicate the effectiveness of using phages Rostov-M3 and Rostov-13 for the prevention of experimental cholera caused by V. cholerae O1 serogroup.
- Open Access
- 10 January 2024
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 4,p. 160-162
Assessment of Cholera Bacteriophages Mixture Safety on an Experimental Animal Model
The spread of Vibrio cholerae strains with multiple antibiotic resistance necessitates the search for alternatives to antibiotics. Cholera bacteriophages can become such means.The aim of the work was to study the safety of a mixture of cholera bacteriophages using an experimental animal model.Materials and methods. We used a composition based on cholera phages Rostov-M3, Rostov-13, FB1. The toxicity of the drug, cytotoxic and apoptogenic effects in experimental animals were assessed.Results and discussion. It has been shown that a single administration of the maximum defined dose of the mixture of phages does not cause negative effects on the body of laboratory animals. Comparison with the control group has not revealed statistically significant differences in the histological picture in the organs of the experimental animals after long-term administration of the drug. Also, after a single and repeated seven-day administration, these phages do not cause apoptosis and necrosis of immune competent cells in experimental animals. The results of the studies indicate the safety of the 3-component phage composition and can be used for the further development of new biological products based on cholera bacteriophages in the future.
- 10 January 2024
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 4,p. 160-162
Open AccessAssessment of Cholera Bacteriophages Mixture Safety on an Experimental Animal Model
The spread of Vibrio cholerae strains with multiple antibiotic resistance necessitates the search for alternatives to antibiotics. Cholera bacteriophages can become such means.The aim of the work was to study the safety of a mixture of cholera bacteriophages using an experimental animal model.Materials and methods. We used a composition based on cholera phages Rostov-M3, Rostov-13, FB1. The toxicity of the drug, cytotoxic and apoptogenic effects in experimental animals were assessed.Results and discussion. It has been shown that a single administration of the maximum defined dose of the mixture of phages does not cause negative effects on the body of laboratory animals. Comparison with the control group has not revealed statistically significant differences in the histological picture in the organs of the experimental animals after long-term administration of the drug. Also, after a single and repeated seven-day administration, these phages do not cause apoptosis and necrosis of immune competent cells in experimental animals. The results of the studies indicate the safety of the 3-component phage composition and can be used for the further development of new biological products based on cholera bacteriophages in the future.
- Open Access
- 1 July 2021
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 98 (3) , 290–297
Biological properties and genetic characteristics of experimental diagnostic Vibrio cholerae bacteriophages
Background. Currently, the researches focused on the design of new diagnostic and preventive preparations based on bacteriophages are underway, so it is importatnt to study the biological properties of cholera phages along with their genetic structure. This information is necessary to predict the phage life cycle and assess the prospects of its practical use in experiments, phagodiagnostics and phagoprophylaxis.Materials and methods. The presence or absence of genes characteristic of temperate bacteriophages was tested using a database created by the authors and developed software "PhageAnalyzer", which allows for rapid analysis of bacteriophage genome-wide sequencing data and prediction of their life cycle.Results and discussion. The morphological structure of experimental diagnostic cholera phages is represented by head bacteriophages of various morphogroups. Negative colonies phage differed in diameter, shape and degree of transparency. No genetic determinants of resistance factors and toxins have been found in the genomes of bacteriophages Rostov-1, Rostov-6, Rostov 7, and Rostov M3. Results of phylogenetic analysis demonstrated that the studied experimental cholera bacteriophages resemble headphages from the genus Vibrio, but are unique, since they lie outside “cluster groups”. Vibrio phages Rostov-1 and Rostov M3 are appeared to be lytic. Genes characteristic of moderate bacteriophages were found in cholera phages Rostov-6 and Rostov 7.Conclusion. The experimental cholera bacteriophage Rostov-1 can be used to differentiate cholera vibrion O1 the serogroup of the El Tor biovar, and Vibrio phage Rostov M3 can be used to differentiate the Classical biovar. Both bacteriophages are lytic and promising components for creating prophylactic drugs against cholera. Vibrio phages Rostov-6 and Rostov 7 can be successfully used only in experimental activities, as well as for monitoring cholera vibrions in the environment. Complete genomic sequences are deposited and available in the international database Genbank (NCBI).
- 1 July 2021
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 98 (3) , 290–297
Open AccessBiological properties and genetic characteristics of experimental diagnostic Vibrio cholerae bacteriophages
Background. Currently, the researches focused on the design of new diagnostic and preventive preparations based on bacteriophages are underway, so it is importatnt to study the biological properties of cholera phages along with their genetic structure. This information is necessary to predict the phage life cycle and assess the prospects of its practical use in experiments, phagodiagnostics and phagoprophylaxis.Materials and methods. The presence or absence of genes characteristic of temperate bacteriophages was tested using a database created by the authors and developed software "PhageAnalyzer", which allows for rapid analysis of bacteriophage genome-wide sequencing data and prediction of their life cycle.Results and discussion. The morphological structure of experimental diagnostic cholera phages is represented by head bacteriophages of various morphogroups. Negative colonies phage differed in diameter, shape and degree of transparency. No genetic determinants of resistance factors and toxins have been found in the genomes of bacteriophages Rostov-1, Rostov-6, Rostov 7, and Rostov M3. Results of phylogenetic analysis demonstrated that the studied experimental cholera bacteriophages resemble headphages from the genus Vibrio, but are unique, since they lie outside “cluster groups”. Vibrio phages Rostov-1 and Rostov M3 are appeared to be lytic. Genes characteristic of moderate bacteriophages were found in cholera phages Rostov-6 and Rostov 7.Conclusion. The experimental cholera bacteriophage Rostov-1 can be used to differentiate cholera vibrion O1 the serogroup of the El Tor biovar, and Vibrio phage Rostov M3 can be used to differentiate the Classical biovar. Both bacteriophages are lytic and promising components for creating prophylactic drugs against cholera. Vibrio phages Rostov-6 and Rostov 7 can be successfully used only in experimental activities, as well as for monitoring cholera vibrions in the environment. Complete genomic sequences are deposited and available in the international database Genbank (NCBI).